When to Use AICD with Pacemaker vs. AICD Only
An AICD with pacemaker functionality (dual-chamber device) is recommended over an AICD-only device when patients have an indication for bradycardia pacing, require antitachycardia pacing for VT termination, or need cardiac resynchronization therapy. 1
Indications for AICD with Pacemaker
Definite Indications (Class I)
- Symptomatic sinus node dysfunction requiring atrial pacing 1
- Documented second- or third-degree AV block requiring pacing 1
- Sustained pause-dependent ventricular tachycardia, with or without QT prolongation 1
- Bradycardia limiting the use of necessary beta-blockers or other negative chronotropic medications 1
Reasonable Indications (Class IIa)
- Bradycardia-induced or pause-dependent ventricular tachyarrhythmias (such as in long QT syndrome with torsades de pointes) 1
- High-risk patients with congenital long-QT syndrome who require both defibrillation and pacing capabilities 1
Possible Indications (Class IIb)
- Documented history of atrial arrhythmias (but not permanent atrial fibrillation) where atrial pacing may be beneficial 1
- Hypertrophic cardiomyopathy with significant resting or provocable left ventricular outflow tract gradient where AV synchrony is important 1
When AICD-Only is Appropriate
- No indication for bradycardia pacing and no anticipated need for pacing in the future 1
- Permanent or longstanding persistent atrial fibrillation with no plans to restore sinus rhythm 1
- Conditions likely to result in VF rather than monomorphic/polymorphic VT without bradycardia-induced mechanisms (e.g., idiopathic ventricular fibrillation, Brugada syndrome, catecholaminergic polymorphic VT, short QT syndrome) 1
Clinical Evidence and Considerations
In the MADIT-II trial, approximately 5.2% of patients with post-MI reduced ejection fraction required pacemaker or CRT implantation during a median follow-up of 20 months, with symptomatic sinus bradycardia being the most common indication (37%) 2
Risk factors for subsequent pacemaker need include:
- PR interval >200 ms (HR = 3.07)
- Prior CABG (HR = 6.88) 2
The DAVID trial demonstrated that unnecessary dual-chamber pacing (DDDR-70) in patients without pacing indications was associated with worse outcomes compared to minimal ventricular backup pacing (VVI-40), highlighting the importance of appropriate device selection 3
Subcutaneous ICD Considerations
Subcutaneous ICDs should NOT be implanted in patients with:
- Indications for bradycardia pacing
- Need for cardiac resynchronization therapy
- Requirement for antitachycardia pacing for VT termination 1
Subcutaneous ICDs are recommended (Class I) for patients who:
- Meet criteria for an ICD
- Have inadequate vascular access or high infection risk
- Have no need for pacing functions 1
Practical Algorithm for Decision-Making
Assess for pacing indications:
Consider cardiac condition:
Evaluate future pacing needs:
Common Pitfalls to Avoid
Unnecessary dual-chamber device implantation in patients without pacing indications can lead to increased complications and potentially worse outcomes 3
Failure to recognize existing or potential bradycardia requiring pacing support, particularly in patients on beta-blockers or other negative chronotropic agents 1
Implanting a subcutaneous ICD in patients who may develop a need for pacing, necessitating a future system replacement 1